An irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1 inhibits estradiol synthesis in human endometriosis lesions and induces regression of the non-human primate endometriosis
This study investigated an irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1, finding it reduces estradiol synthesis in human endometriosis lesions and promotes regression in non-human primate endometriosis models.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (35)
- 17β-Hydroxysteroid Dehydrogenase-2 Deficiency and Progesterone Resistance in Endometriosis via openalex
- Aromatase inhibitor treatment limits progression of peritoneal endometriosis in baboons via openalex
- A sensitive HPLC method for the assessment of metabolic conversion of estrogens via openalex
- Baboon Model for the Study of Endometriosis via openalex
- Endometriosis: Correlation between histologic and visual findings at laparoscopy via openalex
- Endometriosis: pathogenesis and treatment via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Estrogen metabolizing enzymes in endometrium and endometriosis via openalex
- Future of Endometriosis Research via openalex
- Inhibition of Type 1 17β-Hydroxysteroid Dehydrogenase Impairs the Synthesis of 17β-Estradiol in Endometriosis Lesions via openalex
- Intrapelvic injection of menstrual endometrium causes endometriosis in baboons (Papio cynocephalus and Papio anubis) via openalex
- Medical treatment improves social behavior in a primate endometriosis model (<i><scp>C</scp>allithrix jacchus</i>) via openalex
- Nonhuman Primate Models for Translational Research in Endometriosis via openalex
- Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities via openalex
- Pharmacokinetic profile of PBRM in rodents, a first selective covalent inhibitor of 17β-HSD1 for breast cancer and endometriosis treatments via openalex
- W4250243238 via openalex
- W4255215605 via openalex
- W6653119647 via openalex
- W6653207505 via openalex
- W1970075541 via openalex
- W6681249011 via openalex
- W1976691013 via openalex
- W2010993054 via openalex
- W2073883348 via openalex
- W2079236473 via openalex
- W2091259697 via openalex
- W2127285450 via openalex
- W2140313736 via openalex
- W2150454694 via openalex
- W2151970029 via openalex
- W2317201616 via openalex
- W2743803136 via openalex
- W2974555722 via openalex
- W3136770632 via openalex
- W3155054302 via openalex
Cited by (5)
- Electroacupuncture Ameliorates Endometriosis-Associated Ovarian Dysfunction by Activating Nrf2 Pathway to Upregulate GPX4 Function and Inhibiting Ferroptosis 2025
- The Known, the Unknown and the Future of the Pathophysiology of Endometriosis 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis 2022
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-26T00:34:42.998379+00:00